2021-2026 Report on Global Transdermal Drug Patches Market by Player, Region, Type, Application and Sales Channel

The global Transdermal Drug Patches market was valued at $XX million in 2019, and Global Research View analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2019 and 2029.

This report provides detailed historical analysis of global market for Transdermal Drug Patches from 2014-2019, and provides extensive market forecasts from 2020-2029 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Transdermal Drug Patches market.

Leading players of Transdermal Drug Patches including:
Noven
Mylan
Novartis
Johnson & Johnson
Agile Therapeutics
Teikoku Pharma USA
Immune Pharmaceuticals
Hercon Pharmaceuticals
Pocono
DURECT Corporation
Xel Pharmaceuticals

Market split by Type, can be divided into:
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others

Market split by Application, can be divided into:
Used for Hypertension
Used for Contraception
Used for Analgesia
Used for Smoking Cessation
Used for Angina
Used for Hormone Replacement

Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel

Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America Brazil, Argentina, Colombia and Chile etc.)
Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.)

If you have any special requirement, please let us know and we can provide you the report as your requirement.

Table of Contents

Chapter 1 Transdermal Drug Patches Market Overview
1.1 Transdermal Drug Patches Definition
1.2 Global Transdermal Drug Patches Market Size Status and Outlook (2021-2026)
1.3 Global Transdermal Drug Patches Market Size Comparison by Region (2021-2026)
1.4 Global Transdermal Drug Patches Market Size Comparison by Type (2021-2026)
1.5 Global Transdermal Drug Patches Market Size Comparison by Application (2021-2026)
1.6 Global Transdermal Drug Patches Market Size Comparison by Sales Channel (2021-2026)
1.7 Transdermal Drug Patches Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/ Expansion)
Chapter 2 Transdermal Drug Patches Market Segment Analysis by Player
2.1 Global Transdermal Drug Patches Sales and Market Share by Player (2017-2019)
2.2 Global Transdermal Drug Patches Revenue and Market Share by Player (2017-2019)
2.3 Global Transdermal Drug Patches Average Price by Player (2017-2019)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Transdermal Drug Patches Market Segment Analysis by Type
3.1 Global Transdermal Drug Patches Market by Type
3.1.1 Fentanyl Transdermal Patch
3.1.2 Nicotine Transdermal Patch
3.1.3 Buprenorphine Transdermal Patch
3.1.4 Clonidine Transdermal Patch
3.1.5 Oxybutynin Transdermal Patch
3.2 Global Transdermal Drug Patches Sales and Market Share by Type (2014-2019)
3.3 Global Transdermal Drug Patches Revenue and Market Share by Type (2014-2019)
3.4 Global Transdermal Drug Patches Average Price by Type (2014-2019)
3.5 Leading Players of Transdermal Drug Patches by Type in 2019
3.6 Conclusion of Segment by Type
Chapter 4 Transdermal Drug Patches Market Segment Analysis by Application
4.1 Global Transdermal Drug Patches Market by Application
4.1.1 Used for Hypertension
4.1.2 Used for Contraception
4.1.3 Used for Analgesia
4.1.4 Used for Smoking Cessation
4.1.5 Used for Angina
4.2 Global Transdermal Drug Patches Sales and Market Share by Application (2014-2019)
4.3 Leading Consumers of Transdermal Drug Patches by Application in 2019
4.4 Conclusion of Segment by Application
Chapter 5 Transdermal Drug Patches Market Segment Analysis by Sales Channel
5.1 Global Transdermal Drug Patches Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Transdermal Drug Patches Sales and Market Share by Sales Channel (2014-2019)
5.3 Leading Distributors/Dealers of Transdermal Drug Patches by Sales Channel in 2019
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Transdermal Drug Patches Market Segment Analysis by Region
6.1 Global Transdermal Drug Patches Market Size and CAGR by Region (2021-2026)
6.2 Global Transdermal Drug Patches Sales and Market Share by Region (2014-2019)
6.3 Global Transdermal Drug Patches Revenue and Market Share by Region (2014-2019)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Transdermal Drug Patches Market Share by Type
6.4.3 North America Transdermal Drug Patches Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Transdermal Drug Patches Market Share by Type
6.5.3 Europe Transdermal Drug Patches Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Transdermal Drug Patches Market Share by Type
6.6.3 Asia-Pacific Transdermal Drug Patches Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Transdermal Drug Patches Market Share by Type
6.7.3 South America Transdermal Drug Patches Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.7.7 Chile
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Transdermal Drug Patches Market Share by Type
6.8.3 Middle East & Africa Transdermal Drug Patches Market Share by Application
6.8.4 Egypt
6.8.5 Saudi Arabia
6.8.6 South Africa
6.8.7 Nigeria
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Transdermal Drug Patches Players
7.1 Noven
7.1.1 Company Snapshot
7.1.2 Product/Business Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 Strategy and SWOT Analysis
7.2 Mylan
7.3 Novartis
7.4 Johnson & Johnson
7.5 Agile Therapeutics
7.6 Teikoku Pharma USA
7.7 Immune Pharmaceuticals
7.8 Hercon Pharmaceuticals
7.9 Pocono
7.10 DURECT Corporation
7.11 Xel Pharmaceuticals
Chapter 8 Upstream and Downstream Analysis of Transdermal Drug Patches
8.1 Industrial Chain of Transdermal Drug Patches
8.2 Upstream of Transdermal Drug Patches
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process
8.3 Downstream of Transdermal Drug Patches
8.3.1 Leading Distributors/Dealers of Transdermal Drug Patches
8.3.2 Leading Consumers of Transdermal Drug Patches
Chapter 9 Development Trend of Transdermal Drug Patches (2020-2029)
9.1 Global Transdermal Drug Patches Market Size (Sales and Revenue) Forecast (2020-2029)
9.2 Global Transdermal Drug Patches Market Size and CAGR Forecast by Region (2020-2029)
9.3 Global Transdermal Drug Patches Market Size and CAGR Forecast by Type (2020-2029)
9.4 Global Transdermal Drug Patches Market Size and CAGR Forecast by Application (2020-2029)
9.5 Global Transdermal Drug Patches Market Size Forecast by Sales Channel (2020-2029)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

Share This Report

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

Payment Mode

Single User License$3,785.00
Corporate License$5,585.00

About This Report

Category
Report ID90942
CategoryPharma & Healthcare
Published on21-Jun
Publisher NameGlobal Research View

Why us

We are a dynamic team of industry researchers and provide efficient and effective solutions

with trusted and validated data points

  • We offer seamless support at pre and post-sales stage to guide our clients in crucial and strategic business decision plans
  • Innovative research techniques and approaches are implemented to offer key strategic insights
  • Our mission is to offer next to accurate information on fast evolving and dynamic market situations to boost capitalization and revenue acquisition
  • From SMEs to Fortune 500 companies we are the decision support system
  • Fewer assumptions and more precise analysis to foster accurate results
  • We completely believe in insights-driven and data-driven research approach
  • Highlighting forecast on investment feasibility, strategic mergers and acquisitions across       developed, developing and niche markets



REPORT CATEGORIES